Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The objective of the study is to review performance of water soluble contrast study in patients admitted with Small Bowel Obstruction(SBO), will improve quality and safety, and decrease length of stay and morbidity.
Performance of contrast study has been a part of the protocols at multiple institutions of the southwestern surgical congress. Plan to perform a retrospective review of management protocols at these institutions. Wish to know whether the implementation of a standardized, protocol-driven pattern of practice involving the performance of water soluble contrast study in patients admitted with SBO, will improve quality and safety, and decrease length of stay and morbidity.
The objective of the study is to review performance of water soluble contrast study in patients admitted with SBO, will improve quality and safety, and decrease length of stay and morbidity.
Performance of contrast study has been a part of the protocols at multiple institutions of the southwestern surgical congress.
Hypothesize that implementation of a standardized, protocol-driven pattern of practice involving the performance of water soluble contrast study in patients admitted with SBO, will improve quality and safety, and decrease length of stay and morbidity.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| review performance of water soluble contrast | Other | review performance of water soluble contrast study in patients admitted with SBO, will improve quality and safety, and decrease length of stay and morbidity. |
| Measure | Description | Time Frame |
|---|---|---|
| Morbidity and length of stay | Morbidity and length of stay | 1 year |
| Measure | Description | Time Frame |
|---|---|---|
| Patient demographics | number of patients (age, sex, weight, height) | 1 year |
| admit date | Number of patients admitting to the hospital |
Not provided
Inclusion Criteria:
• Adults aged 18-89 years of age
Exclusion Criteria:
• Prisoners
Not provided
Not provided
Previous studies found on an average 3.9 to 9.4% patient suffer from SBO. The disease incidence varies depending on the cause of obstruction. Assuming that 3.9% of the patients will be affected by SBO, the study would require a sample size of 504 for estimating the expected proportion with 3% absolute precision and 95% confidence.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Michael Truitt, MD | The Methodist Hospital Research Institute | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Methodist Dallas Medical Center | Dallas | Texas | 75201 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| 1 year |
| discharge date | number of patients discharging | 1 year |
| admission service | Number of services related to admissions | 1 year |
| Aspirin(ASA )class | number of aspirin class | 1 year |
| comorbidities | number of comorbidities associated | 1 year |
| surgical history | number of surgeries in the past | 1 year |
| labs | number of labs done | 1 year |
| time of contrast given | rate of Contrast given | 1 year |